SCHEDULE 13G

LB Pharmaceuticals Inc

Common Stock, par value $0.0001 · CUSIP: 50180M108

Event date: 2025-12-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Trails Edge Capital Partners, LP

  Shares: 1,268,265.00 · Class: 5.0%

• Trails Edge Biotechnology Master Fund, LP

  Shares: 1,268,265.00 · Class: 5.0%

• Ortav Yehudai

  Shares: 1,268,265.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.